HealWELL AI Inc. Class A · TSX:AIDX
HealWELL AI Inc. Class A — Investor Presentation (November 2024)
21 slides from HealWELL AI Inc. Class A's investor presentation, November 2024
Slide 1: AI Accelerated Preventative Healthcare
Al ACCELERATED PREVENTATIVE HEALTHCARE HEALWELL*4®'! INVESTOR PRESENTATION TSX: AIDX | OTCQX: HWAIF November 2024
Slide 2: Disclaimer & Forward-Looking Statements
HEALWELL*" TSX: AIDX | 2 Disclaimer & Forward-Looking Statements IMPORTANT: YOU MUST READ THE FOLLOWING BEFORE CONTINUING. This presentation has been prepared by HEALWELL Allnc. (t/k/a MCI Onehealth Technologies Inc., the “Company’] for information purposes only and does not constitute an offer to s
Slide 3: Building the world's leading preventative care AI company
HEALWELL*" i TSX: AIDX | 3 HEALWELL is endeavoring to build the world’s leading healthcare technology company focused on Al and data science for preventative care. Our mission is to improve healthcare and save lives through the early identification and detection of disease. INVESTOR PRESENTATION
Slide 4: Accelerated Pace
HEALWELL*" TSX: AIDX | 4 Accelerated Pace October 2, 2023 November 9, 2023 December 22, 2023 April 22, 2024 July 2, 2024 October 22, 2024 ‘BioPharma’ acquisition to expand CRO capabilities and leverage Al in clinical research Investment and strategic partnership with ‘Abstractive Health’ $11.5 milli
Slide 5: Company Overview
HEALWELL*" TSX: AIDX | 5 Company Overview . . Headquarters: + Al-enabled clinical decision support is the future of healthcare. * HEALWELL provides leading Al tools and software to healthcare providers, with the ability to screen and detect hundreds of rare, complex and chronic diseases . Number of
Slide 6: Unlocking the Potential of Healthcare Data
HEALWELL* TSX: AIDX | 6 Unlocking the Potential of Healthcare Data Clinics & Practitioners * Clinical Decision Support * Al Co-Pilot Tools * Patient Risk Stratification * Value-Based Care on Hospitals & Health Systems INVESTOR PRESENTATION HEALWELL*#®'! Driving Value for All Stakeholders E Pharma &
Slide 7: Business Model
HEALWELL*" TSX: AIDX | 7 Business Model HEALWELL Generates Revenue in 3 Distinct Categories: Al and Data Science Re-occurring Revenue ~70% Gross Margin (at scale) High Growth Customers: * Pharma + Life Sciences Companies * Precision Medicine Companies Healthcare Software SaaS Revenue ~80% Gross Marg
Slide 8: Expanding Commercial Footprint
HEALWELL* TSX: AIDX | 8 Expanding Commercial Footprint . Healthcare Clinical Research =e) PENTAVERE © Intrahealth yN POLYCLINIC y A HEALWELL*! COMPANY 7 hospitals, 9 Pharma relationships 415,000 healthcare providers A HEALWELL* COMPANY SERVICES INC. 6 large Pharma relationships 5 provincial health a
Slide 9: Advanced AI Co-Pilots
HEALWELL*" Advanced Al Co-Pilots % ¢) Ca 6 ==) 9 == INVESTOR PRESENTATION TSX: AIDX | Enhances diagnosis and management of rare diseases by delivering specialized clinical insights for more accurate and efficient patient care. Enhances chronic disease management by improving CKD patient risk stratif
Slide 10: Scientific Publications and Validation
TSX: AIDX |10 HEALWELL* Scientific Publications and Validation O+ Publications in high impact, peer- reviewed journals demonstrating groundbreaking Al advancements with industry-leading accuracy. INVESTOR PRESENTATION College of Allergy, Asthma & Immunology JAM A CC) Current Oncology * CANADIAN JOUR
Slide 11: Financial Projections
TSX: AIDX | 11 HEALWELL* Financial Projections Revenue (C$M) Adj. EBITDA (C$M) 44 7.9 = 3 12.7 2024E 2025E 2026E 2024E 2025E 2026E 2023 Mllions (C$) Mlllions (C$) Current Annualized Revenue Run-Rate: $65M+ 2024, 2025, 2026 revenue estimates based on analyst consensus sourced from S&P Capital IQ Anal
Slide 12: Exclusive access to more consenting clinicians
HEALWELL* Exclusive access to more consenting clinicians will allow us to continually refine our algorithms, further positioning us to become a leading force in the field of disease detection software and preventative healthcare. INVESTOR PRESENTATION
Slide 13: M&A Strategy
HEALWELL* TSX: AIDX | 13 M&A Strategy Mature operating healthcare software, Al & Data Science Strategic Investments digital health, and clinical research companies ran PENTAVERE <> doctorly © Intrahealth y) a x! (Qy Verosource Abstractive Health BioPharmaN a, Ne SERVICES INC. / INVESTOR PRESENTATION
Slide 14: End-to-End Pharmaceutical Services Partner
HEALWELL* TSX: AIDX | 14 End-to-End Pharmaceutical Services Partner 1 2 = Beco Gnt Patient Access i Trial Management Al-Driven 3 Al Powered Insights Powered by: Clinical Trial Execution led by: Data Insights provided by: Khure (@ Health Settee TEPENTAVERE Leverages Al-driven solutions to identify an
Slide 15: VeroSource
HEALWELL* TSX: AIDX | 15 VeroSource VeroSource is the patient/practitioner facing technology empowering multiple WELL and HEALWELL technologies. Access 2 OSCAR PRO ii @ Ocean r © Intrahealth (fea nS ae uy , Platform Al Data Input s rey VeroSource SEPENTAVERE INVESTOR PRESENTATION
Slide 16: Share Price Performance
HEALWELL*" TSX: AIDX | 16 Share Price Performance TSX: AIDX 20 : 8 20 Analyst Price Targets a Maxim Group $ to Eight Capital CAPITAL $ 130 we Stifel TFEL $ = Clarus Securities CLARUS $ ‘2 | Tay P5p $ ase Ventum Financial Ventum”? $ oe an feb tat a Noe i 7 Ain Sep ost cae Foaeem Goa pHice $ zon Haywo
Slide 17: Capital Structure
HEALWELL*" TSX: AIDX | 17 Capital Proforma Economic Ownership@) Structu re (Fully Diluted Basis) TICKER TSX: AIDX ISSUED & OUTSTANDING™ 165.88M CONVERTIBLE DEBENTURE SHARES@) 49.47M WARRANTS®) 39.84M OPTIONS / xSUs 9.12M CASH {as of June 30) $19.8M SWELL Health ml Institutional Investors Mgmt/Board
Slide 18: Proven and Experienced Team
HEALWELL* TSX: AIDX | 18 Proven and Experienced Team — Dr. Alexander Dobranowski Anthony Lam CHIEF EXECUTIVE OFFICER CHIEF FINANCIAL OFFICER Medical doctor and entrepreneur with 15+ years of 20+ years of international senior finance and operational clinical and technology experience. CEO of HEALWELL
Slide 19: Board of Directors
HEALWELL* Board of Directors Hamed Shahbazi CHAIRMAN Founder, CEO & Chairman at WELL Health. 20+ years of experience as a technology focused operator. Founder of TIO Networks, acquired by PayPal for $304M. Key driver in more than 70 M&A transactions worth approx. ~$2B. Kingsley Ward > DIRECTOR 4 ‘ F
Slide 20: @ ff
HEALWELL*" TSX: AIDX |20 @ ff INVESTOR PRESENTATION
Slide 21: AI Accelerated Preventative Healthcare
Al ACCELERATED PREVENTATIVE HEALTHCARE HEALWELL*4®'! 460 College Street, Unit 301 Toronto, ON M6G 1A1 | 416-440-4040 © [email protected] in |X| f | © INVESTOR PRESENTATION TSX: AIDX | OTCQX: HWAIF November 2024